ChemPartner PharmaTech Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2023: 0.012x

ChemPartner PharmaTech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, ChemPartner PharmaTech Co Ltd (300149) has a cash flow conversion efficiency ratio of 0.012x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥28.21 Million ≈ $4.13 Million USD) by net assets (CN¥2.37 Billion ≈ $347.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ChemPartner PharmaTech Co Ltd (2007–2025)

Cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. This chart illustrates how ChemPartner PharmaTech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300149 stock price and chart for real-time trading data and today's change.

ChemPartner PharmaTech Co Ltd Cash Flow Conversion Ratio Explained

ChemPartner PharmaTech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ChemPartner PharmaTech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ChemPartner PharmaTech Co Ltd ranked by their cash flow conversion efficiency. Also see ChemPartner PharmaTech Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zero One Technology Co Ltd
TW:3029
-0.020x
Jianglong Shipbuilding Co Ltd
SHE:300589
0.284x
Henan Ancai Hi-tech Co Ltd
SHG:600207
-0.033x
Sharda Cropchem Limited
NSE:SHARDACROP
0.226x
Jiangyin Haida Rubber and Plastic Co Ltd Class A
SHE:300320
0.016x
Huarui Electrical Appliance Co Ltd
SHE:300626
-0.015x
Drugs Made In America Acquisition II Corp. Ordinary Shares
NASDAQ:DMII
0.000x
Pet Acquisition LLC
NASDAQ:WOOF
-0.051x

Annual Cash Flow Conversion Efficiency for ChemPartner PharmaTech Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Review 300149 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.30 Billion
≈ $190.28 Million
CN¥190.50 Million
≈ $27.88 Million
0.146x +7.83%
2024-12-31 CN¥1.24 Billion
≈ $181.17 Million
CN¥168.21 Million
≈ $24.61 Million
0.136x +31.45%
2023-12-31 CN¥1.46 Billion
≈ $213.77 Million
CN¥150.99 Million
≈ $22.09 Million
0.103x -6.04%
2022-12-31 CN¥2.39 Billion
≈ $349.14 Million
CN¥262.46 Million
≈ $38.41 Million
0.110x -42.15%
2021-12-31 CN¥1.99 Billion
≈ $291.06 Million
CN¥378.22 Million
≈ $55.35 Million
0.190x +35.89%
2020-12-31 CN¥2.45 Billion
≈ $358.86 Million
CN¥343.16 Million
≈ $50.22 Million
0.140x +49.86%
2019-12-31 CN¥2.30 Billion
≈ $337.05 Million
CN¥215.07 Million
≈ $31.47 Million
0.093x -15.36%
2018-12-31 CN¥2.20 Billion
≈ $322.59 Million
CN¥243.19 Million
≈ $35.59 Million
0.110x +45.29%
2017-12-31 CN¥835.45 Million
≈ $122.25 Million
CN¥63.43 Million
≈ $9.28 Million
0.076x -17.96%
2016-12-31 CN¥769.93 Million
≈ $112.67 Million
CN¥71.26 Million
≈ $10.43 Million
0.093x -33.47%
2015-12-31 CN¥723.81 Million
≈ $105.92 Million
CN¥100.69 Million
≈ $14.73 Million
0.139x +62.47%
2014-12-31 CN¥696.53 Million
≈ $101.92 Million
CN¥59.63 Million
≈ $8.73 Million
0.086x +23.89%
2013-12-31 CN¥670.29 Million
≈ $98.08 Million
CN¥46.32 Million
≈ $6.78 Million
0.069x -19.60%
2012-12-31 CN¥640.90 Million
≈ $93.78 Million
CN¥55.09 Million
≈ $8.06 Million
0.086x +350.62%
2011-12-31 CN¥611.46 Million
≈ $89.48 Million
CN¥11.66 Million
≈ $1.71 Million
0.019x -47.63%
2010-12-31 CN¥571.30 Million
≈ $83.60 Million
CN¥20.81 Million
≈ $3.05 Million
0.036x -72.23%
2009-12-31 CN¥101.26 Million
≈ $14.82 Million
CN¥13.28 Million
≈ $1.94 Million
0.131x -64.72%
2008-12-31 CN¥58.36 Million
≈ $8.54 Million
CN¥21.70 Million
≈ $3.18 Million
0.372x -59.35%
2007-12-31 CN¥24.25 Million
≈ $3.55 Million
CN¥22.19 Million
≈ $3.25 Million
0.915x --

About ChemPartner PharmaTech Co Ltd

SHE:300149 China Biotechnology
Market Cap
$647.79 Million
CN¥4.43 Billion CNY
Market Cap Rank
#10567 Global
#2769 in China
Share Price
CN¥8.89
Change (1 day)
+11.26%
52-Week Range
CN¥7.55 - CN¥12.74
All Time High
CN¥24.07
About

ChemPartner PharmaTech Co.,Ltd. engages in the microecological nutrition and healthcare businesses worldwide. The company operates in two segments, Microecological Nutrition and Medical Business; and Pharmaceutical Research and Development Service and Production Outsourcing Business. It offers prebiotic products and the provision of microecological medical services. The company provides comprehen… Read more